2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 034
Myynti
Määrä
26 202
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 758 | - | - | ||
| 1 065 | - | - | ||
| 151 | - | - | ||
| 60 | - | - |
Ylin
0,262VWAP
Alin
0,254VaihtoMäärä
0,3 977 540
VWAP
Ylin
0,262Alin
0,254VaihtoMäärä
0,3 977 540
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenShort selling is increasing even today. It feels a bit foolish to short sell in this situation. They won't have time to buy back much if the stock surges,
·1 päivä sittenPerhaps you are assuming Nordnet's 240 mio. SEK in market value.? Nordnet's number of shares and market value are not correct, and I took a quick approximate figure for mental calculation with 600,000 shares and price = 0.25, and 2 % short, and then ca. 3 mio. SEK has been shorted - by those subject to registration, of course. So perhaps it is closer to 4 mio. than to 3, if one brings out the spreadsheet. But no matter what the precise amount is, then it is a ridiculously small amount to short for a professional actor, I think.·1 päivä sittenNo! You made some incorrect assumptions. I have not looked at Noednet's figures. You can find the short selling here: https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=54930011ZA52NKO5W681 Increase today = 0.,23 % Number of shares = 654 244 258 according to Avanza Market capitalization = 169,1 MSEK according to Avanza 0;0282 x 169,1 = 4,77 It will be difficult to buy so many shares on the stock market if the price soars.- ·1 päivä sitten · MuokattuThe price is becoming more and more insane. Not only does one now get all shares in the portfolio completely free, but also gets a discount on the cash that we, who participated in the issue, have put into the company's coffers. If one doesn't believe in the company, one should stay away - but otherwise, one must say that with the current price, which is 20 % below the issue price, one gets the best of both worlds. I have never experienced a stock that so strongly screams for a solvent liquidation to be carried out, all shares to be sold - even if it's at spot price - and the money and cash reserves to be distributed to the shareholders. But don't tell anyone, because then we will never cover the accumulated old loss that most of us old investors have "saved up."
- ·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.
1.2.1.2.They have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·2.2.With this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management. - ·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...
·28.1.That applies to all stocks, for that matter :)
·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenShort selling is increasing even today. It feels a bit foolish to short sell in this situation. They won't have time to buy back much if the stock surges,·1 päivä sittenPerhaps you are assuming Nordnet's 240 mio. SEK in market value.? Nordnet's number of shares and market value are not correct, and I took a quick approximate figure for mental calculation with 600,000 shares and price = 0.25, and 2 % short, and then ca. 3 mio. SEK has been shorted - by those subject to registration, of course. So perhaps it is closer to 4 mio. than to 3, if one brings out the spreadsheet. But no matter what the precise amount is, then it is a ridiculously small amount to short for a professional actor, I think.·1 päivä sittenNo! You made some incorrect assumptions. I have not looked at Noednet's figures. You can find the short selling here: https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=54930011ZA52NKO5W681 Increase today = 0.,23 % Number of shares = 654 244 258 according to Avanza Market capitalization = 169,1 MSEK according to Avanza 0;0282 x 169,1 = 4,77 It will be difficult to buy so many shares on the stock market if the price soars.
- ·1 päivä sitten · MuokattuThe price is becoming more and more insane. Not only does one now get all shares in the portfolio completely free, but also gets a discount on the cash that we, who participated in the issue, have put into the company's coffers. If one doesn't believe in the company, one should stay away - but otherwise, one must say that with the current price, which is 20 % below the issue price, one gets the best of both worlds. I have never experienced a stock that so strongly screams for a solvent liquidation to be carried out, all shares to be sold - even if it's at spot price - and the money and cash reserves to be distributed to the shareholders. But don't tell anyone, because then we will never cover the accumulated old loss that most of us old investors have "saved up."
- ·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.1.2.1.2.They have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·2.2.With this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management.
- ·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
- ·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...·28.1.That applies to all stocks, for that matter :)·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 034
Myynti
Määrä
26 202
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 758 | - | - | ||
| 1 065 | - | - | ||
| 151 | - | - | ||
| 60 | - | - |
Ylin
0,262VWAP
Alin
0,254VaihtoMäärä
0,3 977 540
VWAP
Ylin
0,262Alin
0,254VaihtoMäärä
0,3 977 540
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
85 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenShort selling is increasing even today. It feels a bit foolish to short sell in this situation. They won't have time to buy back much if the stock surges,·1 päivä sittenPerhaps you are assuming Nordnet's 240 mio. SEK in market value.? Nordnet's number of shares and market value are not correct, and I took a quick approximate figure for mental calculation with 600,000 shares and price = 0.25, and 2 % short, and then ca. 3 mio. SEK has been shorted - by those subject to registration, of course. So perhaps it is closer to 4 mio. than to 3, if one brings out the spreadsheet. But no matter what the precise amount is, then it is a ridiculously small amount to short for a professional actor, I think.·1 päivä sittenNo! You made some incorrect assumptions. I have not looked at Noednet's figures. You can find the short selling here: https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=54930011ZA52NKO5W681 Increase today = 0.,23 % Number of shares = 654 244 258 according to Avanza Market capitalization = 169,1 MSEK according to Avanza 0;0282 x 169,1 = 4,77 It will be difficult to buy so many shares on the stock market if the price soars.
- ·1 päivä sitten · MuokattuThe price is becoming more and more insane. Not only does one now get all shares in the portfolio completely free, but also gets a discount on the cash that we, who participated in the issue, have put into the company's coffers. If one doesn't believe in the company, one should stay away - but otherwise, one must say that with the current price, which is 20 % below the issue price, one gets the best of both worlds. I have never experienced a stock that so strongly screams for a solvent liquidation to be carried out, all shares to be sold - even if it's at spot price - and the money and cash reserves to be distributed to the shareholders. But don't tell anyone, because then we will never cover the accumulated old loss that most of us old investors have "saved up."
- ·29.1.The share price is ridiculously low. Ibindex calculates the net asset value discount at 93 %. But in reality, it is much higher. In fact, when you deduct the liquid assets and the small listed share in the portfolio, you get all the unlisted shares completely free and more. Since this catastrophic emission failed (only 21 - 23 % was sold at full price - and only 34 % with a discount), the price of the old ordinary share, now that we know the dilution from the emission, should not be as low as 0.28 at all. The share - which had already fallen sharply - cost 0.63 SEK on the last trading day in November. With the dilution that has now occurred, where the emission was only completed by 57 %, the new price of the ordinary share (and the BTA) should theoretically immediately after the announcement rise to approx. 0.41 SEK, to correspond to the price before the emission. But things always go wrong with emissions in biotech - and this one showed from the start the epitome of incompetent management - unfortunately. But right now, you get all the shares for free if you pay 0.28 SEK, which roughly corresponds to the cash balance. Incredible - but true. And incredible that the main shareholder did not participate in the emission, but merely let their investment be diluted in this foolish way.1.2.1.2.They have little chance to ever make profit on paper because the valuations on the balance sheet are astronomical, let alone finding anyone to buy any of the unlisted assets above the current valuations. You can't even value the cash at cash, because it's going to the investments, like you said, and the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company.·2.2.With this premise " the investment decisions are conducted by unbelievably incompetent people who are going to destroy capital as long as there is enough stupid people to further fund the company." it is clear that you set the value of cash to 0 kr. in the long term. That is essentially also what I write in my analysis, namely that one must of course assess whether one believes in the company's management.
- ·28.1.The result of the issue may come tomorrow. The situation is unstable now and not all BTAs are out yet. It could go either way. BTA from subscription without TR is not finalized. Are there many of them? I note, however, that the turnover is relatively low compared to Medivir.
- ·27.1. · MuokattuNo matter how much this stock goes down, it always seems like there's 100 % left to go down...·28.1.That applies to all stocks, for that matter :)·28.1.The main owner seems not to have subscribed (at least not much, as a total of 21% was subscribed with subscription rights), so it will be very interesting to see the new ownership structure when the dust has settled after some guarantors' sell-off. Hope Anders Hallberg steps in significantly and sorts this out now.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
3 034
Myynti
Määrä
26 202
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 758 | - | - | ||
| 1 065 | - | - | ||
| 151 | - | - | ||
| 60 | - | - |
Ylin
0,262VWAP
Alin
0,254VaihtoMäärä
0,3 977 540
VWAP
Ylin
0,262Alin
0,254VaihtoMäärä
0,3 977 540
Välittäjätilasto
Dataa ei löytynyt